Electromed Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 29 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 37.50.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Electromed Inc is 8.33, ranking 40 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 18.57M, representing a year-over-year increase of 18.43%, while its net profit experienced a year-over-year increase of 58.80%.
Key Metrics
The current valuation score of Electromed Inc is 7.29, ranking 96 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 29.27, which is 87.98% below the recent high of 55.02 and 30.56% above the recent low of 20.32.
The current earnings forecast score of Electromed Inc is 8.00, ranking 66 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 36.00, with a high of 38.00 and a low of 34.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Electromed Inc is 9.62, ranking 3 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 40.46 and the support level at 27.89, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Electromed Inc is 5.00, ranking 110 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 58.36%, representing a quarter-over-quarter decrease of 2.65%. The largest institutional shareholder is James Simons, holding a total of 173.00K shares, representing 2.09% of shares outstanding, with 15.87% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Electromed Inc is 4.95, ranking 91 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.46. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
